Breeze Meds vs MEDVi: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
MEDVi beats Breeze Meds overall, scoring 7.7/10 vs 7.3/10. Breeze Meds is more affordable at $199/mo vs $299/mo. Choose Breeze Meds for users who want a straightforward compounded glp-1 program wi. Choose MEDVi for users who want a low entry price with oral and injectable co.
A side-by-side comparison of Breeze Meds and MEDVi covering pricing, scores, medication types, insurance, and more to help you decide.
Breeze Meds
#34 of 48Compounded GLP-1 provider focused on fast shipping and a no-fuss enrollment process.
Visit Breeze MedsMEDVi
#22 of 48MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake — one of the broader compounded mixes among independent telehealth providers in 2026.
Visit MEDVi| Feature | Breeze Meds | MEDVi |
|---|---|---|
| Our Score | 7.3/10 | 7.7/10 |
| Starting Price | $199/mo | $299/mo |
| Medication Type | Compounded | Both |
| Insurance Accepted | No | No |
| Best For | Users who want a straightforward compounded GLP-1 program with fast shipping | Users who want a low entry price with oral and injectable compounded options |
| Ranking | #34 | #22 |
Pros & Cons Compared
Breeze Meds
Pros
- +No subscription required — order on demand without recurring billing commitments
- +Three formulation options: injectable semaglutide, oral semaglutide tablet, and oral tirzepatide tablet
- +FSA/HSA eligible for those with health savings accounts
- +Discreet packaging on all shipments
Cons
- −Very limited independent reviews and unclear company structure — legitimacy is hard to verify
- −Oral options at $299-399/mo are significantly more expensive than injectable alternatives
- −Not available in all 50 states — varies by provider licensure in your state
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179/mo is competitive for a platform with both oral and injectable compounded formulations
Cons
- −Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Our Verdict
MEDVi edges out Breeze Meds with a score of 7.7/10 vs 7.3/10. If budget is your priority, Breeze Meds starts at $199/mo compared to MEDVi's $299/mo. MEDVi offers both brand-name and compounded medications, giving you more flexibility. Choose Breeze Meds if you want: users who want a straightforward compounded glp-1 program with fast shipping. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.
Still undecided? Editor's #1 Overall Pick
Eden Health GLP-1
$249/mo · 8.9/10 · Both
If neither Breeze Meds nor MEDVi feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Eden Health GLP-1 — strongest balance of clinical oversight, transparent pricing, and verified availability.
Read Full Reviews
Related comparisons
Other matchups readers comparing Breeze Meds or MEDVi tend to look at next.
- Breeze Meds vs MyStart Health$299/mo
- Breeze Meds vs Direct Meds GLP-1$297/mo
- Breeze Meds vs DudeMeds$149/mo
- MEDVi vs Shed$199/mo
- MEDVi vs AgelessRx$340/mo
- MEDVi vs bmiMD$319/mo